Strides Pharma Science STAR.NS · INR

Its shares trade on NSE under the ticker STAR.NS. It has been listed since 3 February 2000. In the fiscal year to 31 March 2025, it reported revenue of ₹45.65bn and net income of ₹35.93bn. At that date it held total assets of ₹60.49bn and shareholders' equity of ₹25.52bn.

Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2000-02-03. The firm is focused on the development and manufacture of IP-led niche and pharmaceutical products. The firm operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The firm manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. The company has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). The company is also engaged in manufacturing soft gelatin capsules. The company develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Arun PillaiExecutive Chairman of the Board, since 2024₹120.0m
• Mr. Badree KomandurChief Executive Officer, Managing Director, Executive Director, since 2010₹44.0m
• Mr. Vikesh KumarGroup Chief Financial Officer and Chief Investor Relations Officer
• Mr. Ramaraju PvsChief Operating Officer
• Ms. Surabhi LoshaliGroup Chief Human Resource Officer
• Ms. Manjula RamamurthyCompliance Officer, Company Secretary₹4.0m
• Mr. Aditya KumarExecutive Director - Business Development, since 2024
• Mr. Umesh KaleChief of Quality Services
• Mr. Subir ChakrabortyNon-Executive Independent Director
• Mr. Ameet HarianiNon-Executive Independent Director₹800,000
• Mr. Homi KhusrokhanNon-Executive Independent Director₹4.0m
• Dr. Kausalya SanthanamNon-Executive Independent Director₹4.0m

Overall

66

Environment

67

Social

70

Governance

61

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.